Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keeton

Showing results (501-510 of 547) with videos related to

Pageof 55
Sort By:
Journal of Consulting and Clinical Psychology|December 9, 2014
Trajectories of change in youth anxiety during cognitive-behavior therapyTara S Peris, Scott N Compton, Philip C Kendall, et al.
Plos One|October 13, 2016
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule TherapeuticsW Joon Chung, Jennifer L Goeckeler-Fried, Viktoria Havasi, et al.
Frontiers in Plant Science|April 19, 2021
SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 PatientsMohau S Makatsa, Marius B Tincho, Jerome M Wendoh, et al.
Journal of Ovarian Research|November 3, 2022
Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancerRebecca M Borneman, Elaine Gavin, Alla Musiyenko, et al.
Journal of Consulting and Clinical Psychology|June 12, 2013
The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youthColleen M Cummings, Nicole E Caporino, Cara A Settipani, et al.
Oncotarget|October 21, 2017
Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signalingBing Zhu, Ashley Lindsey, Nan Li, et al.
Nature Genetics|October 3, 2006
Genome-wide analysis of estrogen receptor binding sitesJason S Carroll, Clifford A Meyer, Jun Song, et al.
Ecological Applications : a Publication of the Ecological Society of America|March 27, 2022
Natural disturbance regimes as a guide for sustainable forest management in EuropeRéka Aszalós, Dominik Thom, Tuomas Aakala, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 11, 2020
Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trialChristoph U Correll, Linmarie Sikich, Gloria Reeves, et al.
Research Square|May 4, 2026
Exploring cardiometabolic markers in adverse pregnancy outcomes: insights from the GROWell studyGeorge E Kuodza, Victoria F Keeton, Logan A Williams, et al.
Pageof 55

Showing results (501-510 of 547) with videos related to

Sort By:
Pageof 55
Journal of Consulting and Clinical Psychology|December 9, 2014
Trajectories of change in youth anxiety during cognitive-behavior therapyTara S Peris, Scott N Compton, Philip C Kendall, et al.
Plos One|October 13, 2016
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule TherapeuticsW Joon Chung, Jennifer L Goeckeler-Fried, Viktoria Havasi, et al.
Frontiers in Plant Science|April 19, 2021
SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 PatientsMohau S Makatsa, Marius B Tincho, Jerome M Wendoh, et al.
Journal of Ovarian Research|November 3, 2022
Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancerRebecca M Borneman, Elaine Gavin, Alla Musiyenko, et al.
Journal of Consulting and Clinical Psychology|June 12, 2013
The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youthColleen M Cummings, Nicole E Caporino, Cara A Settipani, et al.
Oncotarget|October 21, 2017
Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signalingBing Zhu, Ashley Lindsey, Nan Li, et al.
Nature Genetics|October 3, 2006
Genome-wide analysis of estrogen receptor binding sitesJason S Carroll, Clifford A Meyer, Jun Song, et al.
Ecological Applications : a Publication of the Ecological Society of America|March 27, 2022
Natural disturbance regimes as a guide for sustainable forest management in EuropeRéka Aszalós, Dominik Thom, Tuomas Aakala, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 11, 2020
Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trialChristoph U Correll, Linmarie Sikich, Gloria Reeves, et al.
Research Square|May 4, 2026
Exploring cardiometabolic markers in adverse pregnancy outcomes: insights from the GROWell studyGeorge E Kuodza, Victoria F Keeton, Logan A Williams, et al.
Pageof 55